These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21375572)

  • 21. Parents accuse APA of Ritalin conspiracy?
    J Psychosoc Nurs Ment Health Serv; 2000 Oct; 38(10):12. PubMed ID: 11056888
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 23. [Attention deficit with or without hyperactivity disorder: evaluation and drug therapy].
    Beaulieu MJ
    Perspect Infirm; 2012; 9(1):21-3. PubMed ID: 22295448
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of attention deficit hyperactivity disorder.
    Frazier JP; Barratt MS; Smith KC
    J Pediatr Health Care; 1999; 13(5):250-3. PubMed ID: 10776202
    [No Abstract]   [Full Text] [Related]  

  • 25. Standard for maintaining the competence of neonatal nurse practitioners. Position statement #3050.
    National Association of Neonatal Nurse Practitioners
    Adv Neonatal Care; 2010 Dec; 10(6):282-6. PubMed ID: 21102169
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 27. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Zarinara AR; Mohammadi MR; Hazrati N; Tabrizi M; Rezazadeh SA; Rezaie F; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):530-5. PubMed ID: 20860068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 30. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians.
    Epstein JN; Langberg JM; Lichtenstein PK; Mainwaring BA; Luzader CP; Stark LJ
    Pediatrics; 2008 Jul; 122(1):19-27. PubMed ID: 18595982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
    Diller LH
    Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521
    [No Abstract]   [Full Text] [Related]  

  • 32. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 33. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate: prescribing patterns in a South African primary care patient population.
    Truter I
    J Clin Pharm Ther; 2005 Feb; 30(1):59-63. PubMed ID: 15659004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
    Huissoud T; Jeannin A; Dubois-Arber F
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate.
    St Dennis C; Synoground G
    J Sch Nurs; 1996 Feb; 12(1):5-8, 10-1. PubMed ID: 8696016
    [No Abstract]   [Full Text] [Related]  

  • 40. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.